The report maintains SELL citing underutilized capex platforms and margin pressure from a methylamines supply glut and Chinese dumping, despite a Q2 beat.
Read this note →Balaji Amines Limited
NSE BALAMINES BSE 530999 INE050E01027
0 filings · 0 analysed
1,796.70
+32.21%
over 1 year
-
HSIE Results Daily 05 Nov 26 HSIE
The report maintains SELL citing underutilized capex platforms and margin pressure from a methylamines supply glut and Chinese dumping, despite a Q2 beat.
-
Chemicals Q2FY27 Results Preview HSIE
The report expects EBITDA margin to decline 452.7bps QoQ to 20.9% despite 30% YoY revenue growth.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities | 05 Nov 2026, 06:50 | short | 1,771.10 | 1,746.00 | 1,761.50 | 38% | hit |
| HDFC Securities | 14 Oct 2026, 15:45 | short | 2,078.60 | 1,708.00 | 1,761.50 | 86% | open by 2027-10-14 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The report expects EBITDA margin to decline 452.7bps QoQ to 20.9% despite 30% YoY revenue growth.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief